Related Experiment Videos
Alpha 1-antitrypsin and hepatic fibrosis
13rd Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
British Journal of Experimental Pathology
|April 1, 1989
Summary
Alpha 1-antitrypsin administration accelerated liver fibrosis in rats with chronic liver injury. Sialo-alpha 1-antitrypsin also promoted human embryonal lung fibroblast cell growth.
Area of Science:
- Biochemistry
- Hepatology
- Cell Biology
Background:
- Alpha 1-antitrypsin is a proteinase inhibitor with potential therapeutic applications.
- Chronic liver injury is a significant health concern often leading to fibrosis.
- Understanding the role of alpha 1-antitrypsin in liver disease is crucial.
Purpose of the Study:
- To investigate the effect of alpha 1-antitrypsin administration on experimental hepatic fibrosis.
- To evaluate the impact of different forms of alpha 1-antitrypsin (sialo and asialo) on liver fibrosis.
- To assess the influence of alpha 1-antitrypsin on fibroblast cell proliferation.
Main Methods:
- Induction of chronic liver injury in a rat model.
- Administration of sialo and asialo alpha 1-antitrypsin.
- Histological assessment of liver fibrosis.
- Quantification of liver hydroxyproline levels.
- In vitro culture of human embryonal lung fibroblast (HEL) cells.
Main Results:
- Administration of both sialo and asialo alpha 1-antitrypsin accelerated hepatic fibrosis in rats.
- Histological analysis revealed increased fibrosis and elevated hydroxyproline levels in treated livers.
- Sialo-alpha 1-antitrypsin significantly promoted HEL cell growth in culture, while the asialo type showed minimal effect.
Conclusions:
- Alpha 1-antitrypsin, particularly the sialo form, may exacerbate hepatic fibrosis in the context of chronic liver injury.
- Sialo-alpha 1-antitrypsin demonstrates mitogenic effects on fibroblasts, suggesting a potential mechanism for fibrosis acceleration.